Metabolic Psychiatry.

Roped to the anchor.

The previous chapter, The Storming Brain, did one job: it proved, on a century of firm evidence, that changing the brain's fuel can change how it fires. That is the anchor. This chapter is a rope tied to it — and a rope can only reach so far. Everything here is tethered to that one established fact, and the moment a claim strains past what the rope allows, this chapter's job is to say so.

One roof, two very different floors.

"Metabolic psychiatry" gets talked about as one idea, but underneath it are two claims standing at completely different evidence levels. Keeping them apart is the single most important thing on this page.

They're also two separate stories, of very different ages — and that matters, because they're easily confused. The mood-and-illness thread is the older one, with roots going back two decades, grown out of the epilepsy precedent. The reward-and-addiction thread is new, a surprise fallout of the obesity drugs. Different mechanisms, different timelines, different strength of proof. We'll take them in order, and keep an eye on which floor you're standing on.

The clue hiding in the pharmacy.

Start with a fact that's been sitting in plain sight for decades. Several of the drugs used to stabilise bipolar disorder — valproate, lamotrigine, carbamazepine — are the very same drugs used to stop seizures. They were anticonvulsants first; their mood-stabilising power was found second.[1] That overlap is a genuine clue: whatever these molecules do to calm an over-excited, storming brain seems to also help a brain that swings.

And here's the thought that follows, stated plainly as a question: if an over-excitable brain can be steadied by changing its fuel — which is what epilepsy proves — might some of the brain dysregulation in mood and psychotic illness respond to the same lever? That's the brain-energy hypothesis of mental illness: the idea that in at least some people, the problem isn't only the chemistry of a few messengers but the energy supply and metabolic stability of the brain cells making them. It is a hypothesis. It is not established. But it is also not new.

This didn't arrive with the weight-loss drugs.

It's easy to assume metabolic psychiatry is a fad that appeared the moment the GLP-1 drugs made headlines. It isn't. The idea that feeding the brain differently might reach psychiatric illness has its own paper trail, running quietly for twenty years before the obesity drugs arrived — a slow build from animals, to single cases, to case series, to the first small trials.

So the honest picture is the opposite of a bandwagon: a deep, old, slowly-accumulating line of work — and also one that still hasn't cleared the bar that would make it settled. The attention is new; the evidence isn't, and neither is its main limitation.

Old and deep — still a hypothesis.

A long history is not the same as proof, and this is exactly where it would be easy to cheat. Twenty years of case reports, case series and two small pilots build a serious hypothesis — serious enough that major trials are now funded and running. But almost everything above is uncontrolled: people who chose the diet, watched without a comparison group, over short windows. That design can show promise; it cannot rule out placebo, expectation, or the many other things that change when someone overhauls their diet with a supportive team around them.

When the metabolic drugs quieted craving.

The second pillar arrived almost by accident. The GLP-1 drugs built for diabetes and obesity kept producing a side-effect nobody ordered: people reported wanting things less — not only food, but alcohol, and other compulsions. The reward system, it seemed, was being turned down.

What lifts this above anecdote is that it has now been put to the test. In a randomised controlled trial, adults with alcohol use disorder given once-weekly semaglutide cut their heavy drinking compared with placebo.[8] That's a different order of evidence from a pilot — a controlled trial, in a hard-to-treat condition, showing a metabolic drug reaching a psychiatric target: craving itself.

It's still early — one trial, early days, mechanism not fully pinned down. But it's why this pillar stands a clear step higher than the first: the reward-and-addiction thread has crossed from "intriguing observation" into "tested, and it held."

Corroborating, not proof.

It's tempting to tie it all into one grand claim: the brain is a metabolic organ, and fix the metabolism and you fix the mind. The pattern is suggestive — fuel reaches the brain, reward-signalling reaches the brain, and nudging either seems to move psychiatric symptoms. But a pattern of treatments that help is corroborating evidence, not proof of a shared cause. A drug or a diet can touch many systems for many separate reasons.

So the most this chapter will claim is carefully bounded: the brain's energy and reward systems are real levers on how it behaves, and metabolic tools can sometimes reach them. That's a meaningful, hopeful statement. It is a long way short of "mental illness is just metabolic," which the evidence does not support and this site will not pretend it does.

This is where restraint matters most.

Every chapter here carries a "don't change your medication on your own" line. On this one it is not a formality — it is the whole point, because the stakes are the highest and the temptation to overreach is the greatest.

• Never stop or reduce psychiatric medication on the strength of this. Stopping antipsychotics, mood stabilisers or antidepressants abruptly can trigger relapse, crisis, and real danger. This is not negotiable.
• Metabolic approaches are adjuncts, under supervision — never replacements. Where a ketogenic or metabolic intervention is used in psychiatry, it is done with a specialist team, alongside standard care, with monitoring. It is not a self-directed cure.
• If you or someone close is struggling, the move is toward care, not away from it. Bring curiosity about metabolism to a psychiatrist as a question to explore together. The exciting science is a reason to ask more, never a reason to treat yourself.

The excitement is the easy part.

It would be easy to end a chapter like this on a soaring note — the mind reduced to metabolism, every suffering solved by a diet. That ending would be a lie, and the kind that hurts people. The truer ending is quieter and, in its way, more hopeful: there are real, new levers on the brain that we are only beginning to understand; some have already proven themselves; most have not yet; and the only way to tell which is which is the slow, honest work of keeping the tiers apart.

Hold the hope and the humility in the same hand. That is the whole discipline — and it is what makes the hope worth having.